Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Guanylate-Binding Protein 1 as a Potential Predictor of Immunotherapy: A Pan-Cancer Analysis

10 Feb 2022

Abstract excerpt

Background: Mainstream application of cancer immunotherapy is hampered by the low response rate of most cancer patients. A novel immunotherapeutic target or a biomarker predicting response to immunotherapy needs to be developed. Guanylate-binding protein 1 (GBP1) is an interferon (IFN)-inducible guanosine triphosphatases (GTPases) involving inflammation and infection. However, the immunological effects of GBP1 in...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Immunotherapy and Biomarkers
Share to Ferroptosis and cancer prognosis
Share to interferon and immune responses

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 35222540
DOI: 10.3389/fgene.2022.820135

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Guanylate-Binding Protein 1 as a Potential Predictor of Immunotherapy: A Pan-Cancer AnalysisPMID 35222540Read ↗

GBP1 Is a Prognostic Biomarker and Correlates With Immune Infiltrates in Gastric CancerSemantic proximity Read ↗

Critical role of guanylate binding protein 5 in tumor immune microenvironment and predictive value of immunotherapy responseSemantic proximity Read ↗

Multifaceted Roles of Guanylate-Binding Proteins in CancerSemantic proximity Read ↗

Subtyping of microsatellite stability colorectal cancer reveals guanylate binding protein 2 (GBP2) as a potential immunotherapeutic targetSemantic proximity Read ↗

A Multi-Omics Analysis of an Exhausted T Cells’ Molecular Signature in Pan-CancerSemantic proximity Read ↗

TimiGP-Response: the pan-cancer immune landscape associated with response to immunotherapySemantic proximity Read ↗

GPNMB expression impacts prognosis and immune infiltration in cancersSemantic proximity Read ↗

PTBPs: An immunomodulatory-related prognostic biomarker in pan-cancerSemantic proximity Read ↗

Pan-cancer analysis of DEFB1 as a candidate prognostic biomarker and associated with immune infiltrationSemantic proximity Read ↗

Cyclin B1: A potential prognostic and immunological biomarker in pan-cancerSemantic proximity Read ↗

Comprehensive pan-cancer analysis reveals NUSAP1 is a novel predictive biomarker for prognosis and immunotherapy responseSemantic proximity Read ↗

Comprehensive Multiomic Analysis Identified TUBA1C as a Potential Prognostic Biological Marker of Immune-Related Therapy in Pan-Cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.